Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)

Market Cap	2.52B -4.3%
Revenue (ttm)	462.78M -4.4%
Net Income	-238.72M
EPS	-0.64
Shares Out	374.13M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,458,600
Average Volume	8,433,701
Open	6.68
Previous Close	6.74
Day's Range	6.61 - 6.80
52-Week Range	6.24 - 9.09
Beta	0.41
RSI	48.47
Earnings Date	Apr 15, 2026

About SHA:603168

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 2000 and is based in Pinghu, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 1,328
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603168

Financial Performance

In 2025, SHA:603168's revenue was 462.78 million, a decrease of -4.38% compared to the previous year's 483.96 million. Losses were -238.72 million, 93.4% more than in 2024.